Global Tardive Dyskinesia (TD) Treatment Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Tardive Dyskinesia (TD) Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Tardive Dyskinesia (TD) Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tardive Dyskinesia (TD) Treatment Drugs market. Tardive Dyskinesia (TD) Treatment Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tardive Dyskinesia (TD) Treatment Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tardive Dyskinesia (TD) Treatment Drugs market.
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Tardive Dyskinesia (TD) Treatment Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tardive Dyskinesia (TD) Treatment Drugs market. It may include historical data, market segmentation by Type (e.g., Valbenazine, Deutetrabenazine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tardive Dyskinesia (TD) Treatment Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tardive Dyskinesia (TD) Treatment Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tardive Dyskinesia (TD) Treatment Drugs industry. This include advancements in Tardive Dyskinesia (TD) Treatment Drugs technology, Tardive Dyskinesia (TD) Treatment Drugs new entrants, Tardive Dyskinesia (TD) Treatment Drugs new investment, and other innovations that are shaping the future of Tardive Dyskinesia (TD) Treatment Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tardive Dyskinesia (TD) Treatment Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Tardive Dyskinesia (TD) Treatment Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tardive Dyskinesia (TD) Treatment Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tardive Dyskinesia (TD) Treatment Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tardive Dyskinesia (TD) Treatment Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tardive Dyskinesia (TD) Treatment Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tardive Dyskinesia (TD) Treatment Drugs market.
Market Segmentation:
Tardive Dyskinesia (TD) Treatment Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Tardive Dyskinesia (TD) Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Tardive Dyskinesia (TD) Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tardive Dyskinesia (TD) Treatment Drugs market. Tardive Dyskinesia (TD) Treatment Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tardive Dyskinesia (TD) Treatment Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tardive Dyskinesia (TD) Treatment Drugs market.
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Tardive Dyskinesia (TD) Treatment Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tardive Dyskinesia (TD) Treatment Drugs market. It may include historical data, market segmentation by Type (e.g., Valbenazine, Deutetrabenazine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tardive Dyskinesia (TD) Treatment Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tardive Dyskinesia (TD) Treatment Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tardive Dyskinesia (TD) Treatment Drugs industry. This include advancements in Tardive Dyskinesia (TD) Treatment Drugs technology, Tardive Dyskinesia (TD) Treatment Drugs new entrants, Tardive Dyskinesia (TD) Treatment Drugs new investment, and other innovations that are shaping the future of Tardive Dyskinesia (TD) Treatment Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tardive Dyskinesia (TD) Treatment Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Tardive Dyskinesia (TD) Treatment Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tardive Dyskinesia (TD) Treatment Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tardive Dyskinesia (TD) Treatment Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tardive Dyskinesia (TD) Treatment Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tardive Dyskinesia (TD) Treatment Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tardive Dyskinesia (TD) Treatment Drugs market.
Market Segmentation:
Tardive Dyskinesia (TD) Treatment Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Valbenazine
- Deutetrabenazine
- Hospitals
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Neurocrine Biosciences, Inc.
- Teva Pharmaceutical Industries
- Pfizer Inc.
- Biogen
- Novartis AG
- AstraZeneca
- GlaxoSmithKline plc.
- Bayer AG
- Sanofi
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2030
2.1.2 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tardive Dyskinesia (TD) Treatment Drugs Segment by Type
2.2.1 Valbenazine
2.2.2 Deutetrabenazine
2.3 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
2.4 Tardive Dyskinesia (TD) Treatment Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinic
2.4.3 Others
2.5 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
2.5.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
3 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SIZE BY PLAYER
3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Players
3.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS BY REGIONS
4.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (2019-2024)
4.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024)
5.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
5.3 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024)
6.2 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
6.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs by Country (2019-2024)
7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs by Region (2019-2024)
8.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET FORECAST
10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Regions (2025-2030)
10.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Forecast by Country (2025-2030)
10.2.1 United States Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.2 Canada Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.3 Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.4 Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Forecast by Region (2025-2030)
10.3.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.2 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.3 Korea Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.4 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.5 India Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.6 Australia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Forecast by Country (2025-2030)
10.4.1 Germany Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.2 France Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.3 UK Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.4 Italy Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.5 Russia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.2 South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.3 Israel Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.4 Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.5 GCC Countries Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.6 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Type (2025-2030)
10.7 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Neurocrine Biosciences, Inc.
11.1.1 Neurocrine Biosciences, Inc. Company Information
11.1.2 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Neurocrine Biosciences, Inc. Main Business Overview
11.1.5 Neurocrine Biosciences, Inc. Latest Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Information
11.2.2 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Pharmaceutical Industries Main Business Overview
11.2.5 Teva Pharmaceutical Industries Latest Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Inc. Main Business Overview
11.3.5 Pfizer Inc. Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Information
11.5.2 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis AG Main Business Overview
11.5.5 Novartis AG Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Information
11.7.2 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GlaxoSmithKline plc. Main Business Overview
11.7.5 GlaxoSmithKline plc. Latest Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bayer AG Main Business Overview
11.8.5 Bayer AG Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2030
2.1.2 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tardive Dyskinesia (TD) Treatment Drugs Segment by Type
2.2.1 Valbenazine
2.2.2 Deutetrabenazine
2.3 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
2.4 Tardive Dyskinesia (TD) Treatment Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinic
2.4.3 Others
2.5 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
2.5.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
3 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET SIZE BY PLAYER
3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Players
3.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA (TD) TREATMENT DRUGS BY REGIONS
4.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (2019-2024)
4.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024)
5.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
5.3 Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024)
6.2 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
6.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs by Country (2019-2024)
7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs by Region (2019-2024)
8.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARDIVE DYSKINESIA (TD) TREATMENT DRUGS MARKET FORECAST
10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Regions (2025-2030)
10.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.1.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Forecast
10.2 Americas Tardive Dyskinesia (TD) Treatment Drugs Forecast by Country (2025-2030)
10.2.1 United States Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.2 Canada Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.3 Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.2.4 Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3 APAC Tardive Dyskinesia (TD) Treatment Drugs Forecast by Region (2025-2030)
10.3.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.2 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.3 Korea Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.4 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.5 India Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.3.6 Australia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Forecast by Country (2025-2030)
10.4.1 Germany Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.2 France Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.3 UK Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.4 Italy Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.4.5 Russia Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.2 South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.3 Israel Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.4 Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.5.5 GCC Countries Tardive Dyskinesia (TD) Treatment Drugs Market Forecast
10.6 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Type (2025-2030)
10.7 Global Tardive Dyskinesia (TD) Treatment Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Neurocrine Biosciences, Inc.
11.1.1 Neurocrine Biosciences, Inc. Company Information
11.1.2 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Neurocrine Biosciences, Inc. Main Business Overview
11.1.5 Neurocrine Biosciences, Inc. Latest Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Information
11.2.2 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Pharmaceutical Industries Main Business Overview
11.2.5 Teva Pharmaceutical Industries Latest Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Inc. Main Business Overview
11.3.5 Pfizer Inc. Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Information
11.5.2 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Novartis AG Main Business Overview
11.5.5 Novartis AG Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Information
11.7.2 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GlaxoSmithKline plc. Main Business Overview
11.7.5 GlaxoSmithKline plc. Latest Developments
11.8 Bayer AG
11.8.1 Bayer AG Company Information
11.8.2 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bayer AG Main Business Overview
11.8.5 Bayer AG Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offered
11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Valbenazine
Table 3. Major Players of Deutetrabenazine
Table 4. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 7. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 10. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Player (2019-2024)
Table 12. Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Products Offered
Table 13. Tardive Dyskinesia (TD) Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Regions (2019-2024)
Table 18. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 22. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 24. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 26. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 28. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 30. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 32. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 36. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tardive Dyskinesia (TD) Treatment Drugs
Table 45. Key Market Challenges & Risks of Tardive Dyskinesia (TD) Treatment Drugs
Table 46. Key Industry Trends of Tardive Dyskinesia (TD) Treatment Drugs
Table 47. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Neurocrine Biosciences, Inc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 52. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 53. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Neurocrine Biosciences, Inc. Main Business
Table 55. Neurocrine Biosciences, Inc. Latest Developments
Table 56. Teva Pharmaceutical Industries Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 57. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 58. Teva Pharmaceutical Industries Main Business
Table 59. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Teva Pharmaceutical Industries Latest Developments
Table 61. Pfizer Inc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 62. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 63. Pfizer Inc. Main Business
Table 64. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Inc. Latest Developments
Table 66. Biogen Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 67. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 68. Biogen Main Business
Table 69. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Biogen Latest Developments
Table 71. Novartis AG Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 72. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 73. Novartis AG Main Business
Table 74. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Novartis AG Latest Developments
Table 76. AstraZeneca Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 77. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. AstraZeneca Latest Developments
Table 81. GlaxoSmithKline plc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 82. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 83. GlaxoSmithKline plc. Main Business
Table 84. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GlaxoSmithKline plc. Latest Developments
Table 86. Bayer AG Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 87. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 88. Bayer AG Main Business
Table 89. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Bayer AG Latest Developments
Table 91. Sanofi Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 92. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 93. Sanofi Main Business
Table 94. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Sanofi Latest Developments
Table 1. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Valbenazine
Table 3. Major Players of Deutetrabenazine
Table 4. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 7. Tardive Dyskinesia (TD) Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 10. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Player (2019-2024)
Table 12. Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Products Offered
Table 13. Tardive Dyskinesia (TD) Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Regions (2019-2024)
Table 18. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 22. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 24. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 26. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 28. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 30. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 32. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 36. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tardive Dyskinesia (TD) Treatment Drugs
Table 45. Key Market Challenges & Risks of Tardive Dyskinesia (TD) Treatment Drugs
Table 46. Key Industry Trends of Tardive Dyskinesia (TD) Treatment Drugs
Table 47. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Neurocrine Biosciences, Inc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 52. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 53. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Neurocrine Biosciences, Inc. Main Business
Table 55. Neurocrine Biosciences, Inc. Latest Developments
Table 56. Teva Pharmaceutical Industries Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 57. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 58. Teva Pharmaceutical Industries Main Business
Table 59. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Teva Pharmaceutical Industries Latest Developments
Table 61. Pfizer Inc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 62. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 63. Pfizer Inc. Main Business
Table 64. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Inc. Latest Developments
Table 66. Biogen Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 67. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 68. Biogen Main Business
Table 69. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Biogen Latest Developments
Table 71. Novartis AG Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 72. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 73. Novartis AG Main Business
Table 74. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Novartis AG Latest Developments
Table 76. AstraZeneca Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 77. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. AstraZeneca Latest Developments
Table 81. GlaxoSmithKline plc. Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 82. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 83. GlaxoSmithKline plc. Main Business
Table 84. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GlaxoSmithKline plc. Latest Developments
Table 86. Bayer AG Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 87. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 88. Bayer AG Main Business
Table 89. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Bayer AG Latest Developments
Table 91. Sanofi Details, Company Type, Tardive Dyskinesia (TD) Treatment Drugs Area Served and Its Competitors
Table 92. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offered
Table 93. Sanofi Main Business
Table 94. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tardive Dyskinesia (TD) Treatment Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country/Region (2023)
Figure 8. Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type in 2023
Figure 10. Tardive Dyskinesia (TD) Treatment Drugs in Hospitals
Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Tardive Dyskinesia (TD) Treatment Drugs in Clinic
Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Tardive Dyskinesia (TD) Treatment Drugs in Others
Figure 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application in 2023
Figure 17. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Player in 2023
Figure 18. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Tardive Dyskinesia (TD) Treatment Drugs Value Market Share by Country in 2023
Figure 24. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application in 2023
Figure 31. China Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tardive Dyskinesia (TD) Treatment Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country/Region (2023)
Figure 8. Tardive Dyskinesia (TD) Treatment Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type in 2023
Figure 10. Tardive Dyskinesia (TD) Treatment Drugs in Hospitals
Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Tardive Dyskinesia (TD) Treatment Drugs in Clinic
Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Tardive Dyskinesia (TD) Treatment Drugs in Others
Figure 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application in 2023
Figure 17. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Player in 2023
Figure 18. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Tardive Dyskinesia (TD) Treatment Drugs Value Market Share by Country in 2023
Figure 24. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application in 2023
Figure 31. China Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share Forecast by Application (2025-2030)
